This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

11 Feb 2011

GSK Faces Legal Action Over Parkinson's Drug

The British pharmaceutical company is blamed by drug users for its Parkingson's drug causing severely altered mental states.

Requip, or ropinirole, is prescribed to treat Parkinson's Disease. However, GlaxoSmithKline could face legal action after its Requip drug, taken by Parkinson's disease sufferers, was said to cause altered mental states.


A man from the UK is the latest patient to complain about the drug, saying that he became addicted to internet gambling and attempted suicide three times after he was first treated with the medicine eight years ago.



Related News